Natural Therapeutics in Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), represents the hepatic manifestation of metabolic syndrome and is the leading cause of chronic liver disease globally. The disease spectrum extends from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH), progressive fibrosis, cirrhosis, and hepatocellular carcinoma. Given the multi-targeted pathomechanisms of NAFLD—including insulin resistance, lipid dysregulation, oxidative stress, and pro-inflammatory signaling—herbal therapeutics have gained substantial interest. Plants belonging to the genus Ficus (family Moraceae), notably Ficus amplissima, are rich sources of bioactive flavonoids, polyphenols, and terpenoids that exhibit protective metabolic effects. This review synthesizes current insights into the pathophysiology of NAFLD, evaluates natural dietary and herbal interventions, and highlights the therapeutic mechanisms of Ficus amplissima in mitigating hepatic steatosis, dyslipidemia, oxidative stress, and structural liver injury.
Authors
- Arshi Khan*1, Richa Agarwal2, Rajesh Asija3
Publication Details
- Journal
- International Journal of Medical & Pharmaceutical Sciences
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24413579
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00